Literature DB >> 31774554

MiR-3175 promotes epithelial-mesenchymal transition by targeting Smad7 in human conjunctiva and pterygium.

Xincao Zhong1, Jinlong Tang1, Hongyi Li2, Xin Shi1, Yihua Wu3,4, Dajing Xia3,4, Huina Zhang1, Juan Ye1, Han Wu1.   

Abstract

MicroRNAs (miRNAs) are involved in the post-transcriptional regulation of mRNAs. However, the function of miRNAs is unclear in epithelial-mesenchymal transition (EMT) of pterygium, a disease characterized by abnormal fibrovascular proliferation and invasion on the ocular surface. Since MiR-3175 is upregulated in pterygium tissues compared to normal conjunctival tissues, in this study, we investigated the role of MiR-3175 in EMT of a cultured human conjunctival epithelium cell line (CCL) and further validated the findings in pterygium tissues from patients. Our study demonstrates that MiR-3175 promotes proliferation, migration, invasion, and EMT of CCL cells by directly inhibiting Smad7. In conclusion, our data suggested that the MiR-3175-Smad7 axis may play a critical role in pathogenesis and development of pterygium.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  EMT; MiR-3175; Smad7; conjunctiva; pterygium

Year:  2019        PMID: 31774554     DOI: 10.1002/1873-3468.13698

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  DCAF1-targeting microRNA-3175 activates Nrf2 signaling and inhibits dexamethasone-induced oxidative injury in human osteoblasts.

Authors:  Jing Chen; Jin-Qian Liang; Yun-Fang Zhen; Lei Chang; Zhen-Tao Zhou; Xiong-Jie Shen
Journal:  Cell Death Dis       Date:  2021-10-29       Impact factor: 8.469

Review 2.  Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment.

Authors:  Alireza Mafi; Atefe Rahmati; Zahra Babaei Aghdam; Raziyeh Salami; Marziyeh Salami; Omid Vakili; Esmat Aghadavod
Journal:  Cell Mol Biol Lett       Date:  2022-08-03       Impact factor: 8.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.